The final version of the "Survey on the Impact of Novel Coronavirus Infection (COVID-19) on Patient groups/associations with Rare and Intractable Diseases" conducted by ASrid is now available.

2021.07.01 19:02

The final report of the "Survey on the Impact of Novel Coronavirus Infection (COVID-19) on Patient groups/associations with Rare and Intractable Diseases" conducted by ASrid is now available. 

A comparison with the situation in the Asia-Pacific region is also being conducted. 

We would like to express our heartfelt gratitude to the patient groups, patient associations, and NANBYO regional centers for their cooperation.

We also sincerely appreciate NANBYO Forum Executive Committee, OrphanPacific, Inc., DAIICHI SANKYO COMPANY, LIMITED, and Novartis Japan, for their financial supports.

COVID-19 situation in Japanhttps://asrid.org/en/covid19_nanbyo